{"id":73059,"date":"2023-09-13T15:00:01","date_gmt":"2023-09-13T13:00:01","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?post_type=resources&p=73059"},"modified":"2026-01-27T15:36:22","modified_gmt":"2026-01-27T14:36:22","slug":"veeva-introduces-study-portal-and-veevaid-to-streamline-research-site-trial-execution","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/eu\/resources\/veeva-introduces-study-portal-and-veevaid-to-streamline-research-site-trial-execution\/","title":{"rendered":"勛圖惇蹋 Introduces Study Portal and 勛圖惇蹋ID to Streamline Research Site Trial Execution"},"content":{"rendered":"

Sites will be able to easily access systems across multiple sponsors and studies for
increased efficiency and speed<\/em><\/p>\n

BARCELONA, Spain \u2014 13 Sept. 2023<\/strong> \u2014 勛圖惇蹋 Systems<\/a> (NYSE: VEEV) today announced 勛圖惇蹋 Study Portal, a free cloud application to simplify research site access to sponsor technologies. Study Portal will make it easy for clinical researchers to create and share study profiles containing links to all the relevant sponsor technology systems used for a clinical trial. Users will be able to securely store their individual usernames and passwords with the study profile rather than managing multiple links, usernames, and passwords on sticky notes or spreadsheets. Study Portal will work with all sponsor technology systems.<\/p>\n

In addition to Study Portal, 勛圖惇蹋 announced 勛圖惇蹋ID to provide single sign-on for clinical researchers across all sponsor systems, such as 勛圖惇蹋 EDC<\/a>, 勛圖惇蹋 Study Training<\/a>, and 勛圖惇蹋 RTSM<\/a>. When sponsors use 勛圖惇蹋 technology and enable 勛圖惇蹋ID, the access links in Study Portal will take the user directly to the relevant study screen via single sign-on with no additional username and password required.<\/p>\n

\u201cResearch sites are focused on patient care, so alleviating the administrative burden of managing large lists of credentials across studies and partners is not a luxury but a necessity,\u201d said Dr. Vivi\u00ebnne van de Walle, principal investigator, medical director, PT&R. \u201c勛圖惇蹋 Study Portal is a significant step forward to simplify the technology experience for sites. By providing this at no cost to sites, 勛圖惇蹋 is delivering on the vision of offering solutions that are centric to the needs of sites.\u201d<\/p>\n

勛圖惇蹋ID will also be open to 勛圖惇蹋 partners who join the 勛圖惇蹋ID partner program, adhere to security standards, and have integrated the 勛圖惇蹋ID technology. The program will allow third-party vendors to authenticate using 勛圖惇蹋ID for direct system entry through the Study Portal.<\/p>\n

勛圖惇蹋 Study Portal and 勛圖惇蹋ID are planned for availability in December 2023. 勛圖惇蹋 provides free technology solutions to research sites as part of its mission as a Public Benefit Corporation (PBC). Learn more about 勛圖惇蹋 Study Portal at 勛圖惇蹋 SiteVault<\/a>.<\/p>\n

Additional Information<\/strong>
\nFor more on 勛圖惇蹋\u2019s site solutions, visit sites.veeva.com<\/a>
\nConnect with 勛圖惇蹋 on LinkedIn: linkedin.com\/company\/veeva-systems<\/a><\/p>\n

About 勛圖惇蹋 Systems<\/strong>
\n勛圖惇蹋 is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, 勛圖惇蹋 serves more than 1,000 customers, ranging from the world\u2019s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation<\/a>, 勛圖惇蹋 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com<\/a>.<\/p>\n

勛圖惇蹋 Forward-looking Statements<\/strong>
\nThis release contains forward-looking statements regarding 勛圖惇蹋\u2019s products and services and the expected results or benefits from use of our products and services, including certain of our new solutions and applications that are still under development or not generally available. These statements are based on our current expectations. Actual results, availability, and any future events relating to these products and services could differ materially from those anticipated or provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2023, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 38 and 39), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.<\/p>\n

###<\/p>\n

\nContact:<\/strong>
\t
\nJeremy Whittaker
\n勛圖惇蹋 Systems
\n+49-695-095-5486
\njeremy.whittaker@veeva.com<\/a><\/p>\n

\nContact:<\/strong>
\t
\nDeivis Mercado
\n勛圖惇蹋 Systems
\n925-226-8821
\ndeivis.mercado@veeva.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Sites will be able to easily access systems across multiple sponsors and studies for increased efficiency and speed.<\/p>\n","protected":false},"featured_media":73079,"parent":0,"template":"","class_list":["post-73059","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-html-content-yes","resource-area-20-clinical-operations","resource-area-20-vault-platform-area","resource-product-20-sponsor-site-collaboration","resource-product-20-vault-platform","resource-type-news-press-release","resource-type-press-release"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/73059"}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":2,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/73059\/revisions"}],"predecessor-version":[{"id":85432,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/73059\/revisions\/85432"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media\/73079"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=73059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}